AstraZeneca Said To Be Looking To Sell Off Medtech Unit
This article was originally published in The Pink Sheet Daily
Executive Summary
UK pharma seeks $2 billion price tag for dental implants firm Astra Tech.
You may also be interested in...
Capsugel Could Land In Private Equity If Pfizer Divests
Few companies have feet as firmly planted in both the pharma and supplement worlds as Capsugel, the world's largest manufacturer of empty gelatin capsules.
Bristol Flying Solo As A Pure Biopharma After Mead Johnson Spin Out
Decision to split off the nutritionals unit - Bristol's last diversified business - reflects management's improved confidence in the biopharma business and strength of Mead Johnson's stock price.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.